These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1696952)

  • 1. From the World Health Organization. Development of dengue and Japanese encephalitis vaccines.
    Brandt WE
    J Infect Dis; 1990 Sep; 162(3):577-83. PubMed ID: 1696952
    [No Abstract]   [Full Text] [Related]  

  • 2. Vaccines aplenty.
    Halstead SB
    Curr Opin Infect Dis; 2002 Oct; 15(5):461-3. PubMed ID: 12686876
    [No Abstract]   [Full Text] [Related]  

  • 3. Development of new vaccines against dengue fever and Japanese encephalitis.
    Kinney RM; Huang CY
    Intervirology; 2001; 44(2-3):176-97. PubMed ID: 11509879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Empirically derived live-attenuated vaccines against dengue and Japanese encephalitis.
    Saluzzo JF
    Adv Virus Res; 2003; 61():419-43. PubMed ID: 14714439
    [No Abstract]   [Full Text] [Related]  

  • 5. The immunogenicity of tetravalent dengue DNA vaccine in mice pre-exposed to Japanese encephalitis or Dengue virus antigens.
    Prompetchara E; Ketloy C; Keelapang P; Sittisombut N; Ruxrungtham K
    Asian Pac J Allergy Immunol; 2015 Sep; 33(3):182-8. PubMed ID: 26342114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dengue fever virus and Japanese encephalitis virus synthetic peptides, with motifs to fit HLA class I haplotypes prevalent in human populations in endemic regions, can be used for application to skin Langerhans cells to prime antiviral CD8+ cytotoxic T cells (CTLs)--a novel approach to the protection of humans.
    Becker Y
    Virus Genes; 1994 Sep; 9(1):33-45. PubMed ID: 7871759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine development against dengue and Japanese encephalitis: report of a World Health Organization meeting.
    Chambers TJ; Tsai TF; Pervikov Y; Monath TP
    Vaccine; 1997 Oct; 15(14):1494-502. PubMed ID: 9330458
    [No Abstract]   [Full Text] [Related]  

  • 8. From the World Health Organization. Current approaches to the development of dengue vaccines and related aspects of the molecular biology of flaviviruses.
    Brandt WE
    J Infect Dis; 1988 May; 157(5):1105-11. PubMed ID: 2452218
    [No Abstract]   [Full Text] [Related]  

  • 9. The chimeric Japanese encephalitis/Dengue 2 virus protects mice from challenge by both dengue virus and JEV virulent virus.
    Yang J; Yang H; Li Z; Lin H; Zhao Y; Wang W; Tan S; Zeng X; Li Y
    Protein Cell; 2017 Mar; 8(3):225-229. PubMed ID: 28124229
    [No Abstract]   [Full Text] [Related]  

  • 10. Japanese encephalitis vaccines.
    Wkly Epidemiol Rec; 1998 Oct; 73(44):337-44. PubMed ID: 9817024
    [No Abstract]   [Full Text] [Related]  

  • 11. Protection against Japanese encephalitis by inactivated vaccines.
    Hoke CH; Nisalak A; Sangawhipa N; Jatanasen S; Laorakapongse T; Innis BL; Kotchasenee S; Gingrich JB; Latendresse J; Fukai K
    N Engl J Med; 1988 Sep; 319(10):608-14. PubMed ID: 2842677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel dengue virus serotype 1 vaccine candidate based on Japanese encephalitis virus vaccine strain SA14-14-2 as the backbone.
    Yang H; Li Z; Lin H; Wang W; Yang J; Liu L; Zeng X; Wu Y; Yu Y; Li Y
    Arch Virol; 2016 Jun; 161(6):1517-26. PubMed ID: 26976137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Japanese encephalitis and dengue vaccines.
    Barrett AD
    Biologicals; 1997 Mar; 25(1):27-34. PubMed ID: 9167006
    [No Abstract]   [Full Text] [Related]  

  • 14. Construction and preliminary investigation of a novel dengue serotype 4 chimeric virus using Japanese encephalitis vaccine strain SA14-14-2 as the backbone.
    Li Z; Yang H; Yang J; Lin H; Wang W; Liu L; Zhao Y; Liu L; Zeng X; Yu Y; Li Y
    Virus Res; 2014 Oct; 191():10-20. PubMed ID: 25091563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Japanese encephalitis: a Chinese solution?
    Steinhoff MC
    Lancet; 1996 Jun; 347(9015):1570-1. PubMed ID: 8667861
    [No Abstract]   [Full Text] [Related]  

  • 16. Vectors expressing chimeric Japanese encephalitis dengue 2 viruses.
    Wei Y; Wang S; Wang X
    Acta Virol; 2014; 58(4):340-7. PubMed ID: 25518715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential immunization procedure against Group B arboviruses using living attenuated 17D yellow fever virus, living attenuated Langat E5 virus, and living attenuated dengue 2 virus (New Guinea C isolate).
    Price WH; Casals J; Thind I; O'Leary W
    Am J Trop Med Hyg; 1973 Jul; 22(4):509-23. PubMed ID: 4352231
    [No Abstract]   [Full Text] [Related]  

  • 18. Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses.
    Guy B; Guirakhoo F; Barban V; Higgs S; Monath TP; Lang J
    Vaccine; 2010 Jan; 28(3):632-49. PubMed ID: 19808029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A chimeric live attenuated vaccine against Japanese encephalitis.
    Jones T
    Expert Rev Vaccines; 2004 Jun; 3(3):243-8. PubMed ID: 15176941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excellence in research is not enough.
    Russell PK
    Am J Trop Med Hyg; 1984 May; 33(3):319-24. PubMed ID: 6329009
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.